Display Settings:

Format

Send to:

Choose Destination
    Surgery. 2002 Jan;131(1 Suppl):S159-64.

    Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities.

    Source

    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

    Abstract

    Intrahepatic cholangiocarcinoma (IHCC) is a primary adenocarcinoma of the liver, arising from the intrahepatic bile ducts. The prognosis is generally poor because locoregional extension is usually advanced at the time of diagnosis. Even after a resection, the outcome for patients with advanced IHCC is extremely poor, and the presence of lymph node metastasis has been reported in most previous studies to be the worst prognostic factor after a resection. There are no clear guidelines on lymph node dissection with IHCC. In this article, we review the mode of invasion and the therapeutic modalities: hepatic resection, lymph node dissection, liver transplantation, radiation, and chemotherapy for IHCC.

    PMID:
    11821804
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk